company background image
2864 logo

Shaanxi Panlong Pharmaceutical Group Limited By Share SZSE:002864 Stock Report

Last Price

CN¥28.91

Market Cap

CN¥3.0b

7D

-9.9%

1Y

-27.0%

Updated

27 Mar, 2024

Data

Company Financials +

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd

SZSE:002864 Stock Report

Market Cap: CN¥3.0b

2864 Stock Overview

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China.

2864 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance3/6
Financial Health5/6
Dividends3/6

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shaanxi Panlong Pharmaceutical Group Limited By Share
Historical stock prices
Current Share PriceCN¥28.91
52 Week HighCN¥51.57
52 Week LowCN¥22.00
Beta-0.14
1 Month Change-6.80%
3 Month Change-22.03%
1 Year Change-26.98%
3 Year Change24.77%
5 Year Change-16.64%
Change since IPO100.21%

Recent News & Updates

Earnings Not Telling The Story For Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SZSE:002864) After Shares Rise 32%

Mar 06
Earnings Not Telling The Story For Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SZSE:002864) After Shares Rise 32%

Recent updates

Earnings Not Telling The Story For Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SZSE:002864) After Shares Rise 32%

Mar 06
Earnings Not Telling The Story For Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SZSE:002864) After Shares Rise 32%

Shareholder Returns

2864CN PharmaceuticalsCN Market
7D-9.9%-3.4%-2.2%
1Y-27.0%-11.4%-14.8%

Return vs Industry: 002864 underperformed the CN Pharmaceuticals industry which returned -11.4% over the past year.

Return vs Market: 002864 underperformed the CN Market which returned -14.8% over the past year.

Price Volatility

Is 2864's price volatile compared to industry and market?
2864 volatility
2864 Average Weekly Movement8.1%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement8.1%
10% most volatile stocks in CN Market11.4%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 002864's share price has been volatile over the past 3 months.

Volatility Over Time: 002864's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1997935Xiaolin Xiehttps://www.pljt.com

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. The company was founded in 1997 and is based in Xi'an, China.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Fundamentals Summary

How do Shaanxi Panlong Pharmaceutical Group Limited By Share's earnings and revenue compare to its market cap?
2864 fundamental statistics
Market capCN¥3.04b
Earnings (TTM)CN¥107.30m
Revenue (TTM)CN¥997.08m

28.3x

P/E Ratio

3.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2864 income statement (TTM)
RevenueCN¥997.08m
Cost of RevenueCN¥417.30m
Gross ProfitCN¥579.78m
Other ExpensesCN¥472.48m
EarningsCN¥107.30m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Apr 26, 2024

Earnings per share (EPS)1.02
Gross Margin58.15%
Net Profit Margin10.76%
Debt/Equity Ratio6.6%

How did 2864 perform over the long term?

See historical performance and comparison

Dividends

0.7%

Current Dividend Yield

17%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.